⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 9, 2024Neurology

Effectiveness and Safety of High-efficacy Disease-modifying Therapy in Pediatric Multiple Sclerosis: A Retrospective Analysis at a Single Center (P4-6.017)

R. J. Walsh Keith Van Haren

View Full Paper

Ask AI

Bookmark

Share

Abstract

To assess the safety and effectiveness of high-efficacy disease-modifying therapies (DMT) in children with multiple sclerosis (MS).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Walsh et al. (2024) studied this question.

synapsesocial.com/papers/68e6fcc5b6db64358767737d https://doi.org/10.1212/wnl.0000000000206701

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Treatment of multiple sclerosis in children: review of clinical trialsHuman Clinical Trial · 2023 · 2 citations
2Disease Modifying Therapy Utilization in Pediatric Multiple Sclerosis: A Multi-center Retrospective Study (P1-6.008)2024
3Analysis of the efficacy and safety of first- and second-line disease-modifying drugs for multiple sclerosis in treatment of pediatric multiple sclerosis2025
4EFFICACY AND SAFETY OF HIGH-EFFICACY VERSUS MODERATE-EFFICACY DMTS IN EARLY RELAPSING-REMITTING MS: A NARRATIVE REVIEWSystematic Review · 2026
5Real‐World Effectiveness of Initial Disease‐Modifying Therapies in Pediatric <scp>Multiple Sclerosis</scp>cohort · 2020 · 119 citations